CiVi Biopharma ApS — Credit Rating and Financial Key Figures

CiVi Biopharma ApS (CVR number: 38027794) is a company from KØBENHAVN. The company recorded a gross profit of 610.5 kDKK in 2024. The operating profit was -1464.9 kDKK, while net earnings were -1410.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -114.4 %, which can be considered poor and Return on Equity (ROE) was -180.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 60.9 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. CiVi Biopharma ApS's liquidity measured by quick ratio was 2.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.